Status:
AVAILABLE
IFx-Hu2.0 Expanded Access Program
Lead Sponsor:
TuHURA Biosciences, Inc.
Conditions:
Cutaneous Melanoma, Stage III
Cutaneous Melanoma, Stage IV
Eligibility:
All Genders
18+ years
Brief Summary
Expanded access requests for IFx-Hu2.0 may be considered for the treatment of adult patients (greater than or equal to 18 years of age) with stage III through IV cutaneous melanoma, advanced Merkel ce...
Eligibility Criteria
Inclusion
- To request more information use Responsible Party contact information provided in this record
Exclusion
- To request more information use Responsible Party contact information provided in this record
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04853602
Last Update
August 12 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.